Fighting childhood cancer, one cup at a time.
ALSF funded researchers like Dr. Todd Druley, pictured above, are closer than ever before to finding cures by studying DNA building blocks specific to childhood leukemia.
by Trish Adkins
When a child is first diagnosed with leukemia, the goal is to force the disease into remission. The treatment protocol is long and grueling—at least 2 1/2 years of chemotherapy, lumbar punctures and clinic visits. Today, children diagnosed with the most common form of pediatric leukemia—acute lymphoblastic leukemia (ALL)—have a high cure rate. The discovery of genetic differences that can increase a child’s risk... Read More
Neuroblastoma, the type of cancer our founder Alex Scott battled, is the most-common extra-cranial solid tumor in childhood. Alex’s Lemonade Stand Foundation (ALSF) has helped power research that is getting us closer to cures every day. Researchers like Dr. John Maris from the Children’s Hospital of Philadelphia (CHOP) and Dr. Katherine Matthay from the University of California San Francisco School of Medicine, who sit on the ALSF Scientific Advisory Board, are working to study what makes neuroblastoma tick — to... Read More
Twelve years ago, in 2005, Alex’s Lemonade Stand Foundation gave its first grant to the Children’s Hospital of Philadelphia. As we continue Alex's legacy, ALSF continues to raise funds for cutting-edge research, moving the world closer and closer to cures and more effective, less toxic treatments for childhood cancer.
Recently, we introduced you to future pediatric oncology nurse Taylor, who is alive today because of a breakthrough treatment funded by ALSF. Treatment after... Read More
